Equities

Bactiquant A/S

Bactiquant A/S

Actions
  • Price (DKK)3.35
  • Today's Change-0.13 / -3.74%
  • Shares traded27.31k
  • 1 Year change-43.25%
  • Beta--
Data delayed at least 15 minutes, as of May 08 2024 16:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bactiquant A/S is a Denmark-based Company developing a technology, which aims to monitor bacterial contamination levels in water. Bactiquant operates through seven business segments: Aquaculture, Water Utility, Industry, Data Centres, Oil and Gas, Legionella Risk Assessment and Research Institutions. The Company serves customers that come from such industries as public water utility companies, industries needing water cooling or requiring wastewater treatment, as well as aquaculture and operates in five continents.

  • Revenue in DKK (TTM)12.30m
  • Net income in DKK-13.10m
  • Incorporated1999
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Dextech Medical AB0.00-2.89m58.71m1.00--2.98-----0.2449-0.24490.001.67-----------28.96---29.94------------0.00------12.89--0.412--
Sprint Bioscience AB32.20m-281.26k60.56m28.00--3.4213,565.051.88-0.0064-0.00640.72320.39781.01--7.581,803,036.00-0.8838-71.22-1.58-113.7182.7762.75-0.8735-110.22----0.00--60,725.3022.9999.27---26.02--
Wntresearch AB0.00-20.71m60.76m2.00--1.80-----0.1108-0.11080.000.06090.00----0.00-134.85-100.71-166.68-123.59------------0.00-------5.65------
Toleranzia AB0.00-4.76m62.84m----0.6419-----0.0597-0.05970.000.7790.00-------5.21-7.45-5.43-7.78------------0.0055------11.79--63.90--
Opticept Technologies AB5.83m-51.25m65.28m29.00--0.2245--11.19-2.62-2.620.298110.800.0213-0.06382.37315,344.80-18.69-41.76-21.19-46.21125.8862.65-879.63-882.410.6163-14.160.0566---12.9049.1719.80--45.22--
AroCell AB (publ)27.45m-37.82m65.38m----0.6264--2.38-0.2574-0.25740.18680.71040.20956.686.52---28.86-29.25-30.70-31.37-4.38-9.85-137.78-231.195.25--0.00--16.37122.92-0.5494------
Bioextrax AB publ1.31m-13.72m65.59m----4.28--50.00-0.8026-0.80260.07690.69680.0681--124.67---71.18-86.39-82.24-110.8434.95---1,045.55-2,119.90--------420.5124.40-15.21--56.86--
Odi Pharma AB (publ)521.95k-2.53m68.92m----53.07--132.04-0.2608-0.26080.05380.13380.10841.226.98---52.58---95.24---53.07---484.96--1.32-14.100.00---55.44--4.67------
Bio-Works Technologies AB28.00m-36.24m70.11m38.00--2.50--2.50-1.58-1.581.221.130.5711.825.831,155,158.00-73.91-49.14-101.72-57.9061.1069.88-129.44-168.302.79--0.00--6.2346.24-26.41--1.95--
Isofol Medical AB (publ)459.84k-23.64m74.68m3.00--0.9643--162.41-0.233-0.2330.00450.75180.0041--0.0728240,333.30-21.15-66.73-26.32-88.27-4,773.37---5,141.61-1,023.62----0.00---94.37--76.80------
Circa Group AS12.52m-44.58m75.08m17.00--0.3172--6.00-0.6085-0.60850.17113.040.042--0.98121,154,690.00-14.94---18.01--80.23---355.99--1.99--0.00--41.73---0.0491------
Bactiquant A/S12.30m-13.10m78.72m----5.46--6.40-0.6358-0.63580.59710.61330.50553.672.83---53.83-41.26-62.59-47.16-6.1412.89-106.51-71.775.43-8.540.0431---0.689--7.62------
Biovica International AB3.81m-78.44m81.46m37.00--1.01--21.37-2.42-2.420.1151.620.033-0.30538.43170,800.00-67.80-42.10-74.69-46.33110.09277.88-2,057.41-2,149.687.10--0.057--65.434.44-84.14---20.20--
New Nordic Healthbrands AB340.48m-3.95m82.18m73.00--1.22--0.2414-1.00-1.0086.1717.112.131.724.897,313,014.00-2.475.36-5.5510.5565.2367.30-1.162.380.8906-1.150.213847.969.516.28-119.41--28.36--
StenoCare A/S3.76m-17.57m90.08m9.00--3.44--23.97-1.29-1.290.2711.420.0967--1.25417,535.60-45.21-28.15-63.19-35.47-----467.55-371.061.30-5.540.2727---16.30---7.77------
Xintela AB49.75k-34.50m94.02m----33.66--1,890.02-0.1524-0.15240.00020.00770.0036--0.0088---252.09-181.06-1,065.04-391.61100.00---69,343.59-235,894.00---50.470.00-----45.5418.32---61.47--
Data as of May 08 2024. Currency figures normalised to Bactiquant A/S's reporting currency: Danish Krone DKK
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.